IRIX
Price
$0.88
Change
-$0.00 (-0.00%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
48.42M
38 days until earnings call
NEO
Price
$7.31
Change
+$0.14 (+1.95%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
2.01B
30 days until earnings call
Interact to see
Advertisement

IRIX vs NEO

Header iconIRIX vs NEO Comparison
Open Charts IRIX vs NEOBanner chart's image
IRIDEX
Price$0.88
Change-$0.00 (-0.00%)
Volume$200
Capitalization48.42M
NeoGenomics
Price$7.31
Change+$0.14 (+1.95%)
Volume$20.55K
Capitalization2.01B
IRIX vs NEO Comparison Chart in %
Loading...
IRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRIX vs. NEO commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRIX is a Buy and NEO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (IRIX: $0.88 vs. NEO: $7.17)
Brand notoriety: IRIX and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IRIX: 194% vs. NEO: 93%
Market capitalization -- IRIX: $48.42M vs. NEO: $2.01B
IRIX [@Medical Specialties] is valued at $48.42M. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRIX’s FA Score shows that 1 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • IRIX’s FA Score: 1 green, 4 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, IRIX is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRIX’s TA Score shows that 2 TA indicator(s) are bullish while NEO’s TA Score has 3 bullish TA indicator(s).

  • IRIX’s TA Score: 2 bullish, 6 bearish.
  • NEO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, NEO is a better buy in the short-term than IRIX.

Price Growth

IRIX (@Medical Specialties) experienced а -5.68% price change this week, while NEO (@Medical Specialties) price change was +2.43% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.51%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was +2.89%.

Reported Earning Dates

IRIX is expected to report earnings on Aug 07, 2025.

NEO is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+2.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than IRIX($48.4M). IRIX YTD gains are higher at: -47.619 vs. NEO (-56.493). IRIX has higher annual earnings (EBITDA): -6.79M vs. NEO (-17.61M). NEO has more cash in the bank: 415M vs. IRIX (9.82M). IRIX has less debt than NEO: IRIX (1.26M) vs NEO (612M). NEO has higher revenues than IRIX: NEO (592M) vs IRIX (56.4M).
IRIXNEOIRIX / NEO
Capitalization48.4M2.01B2%
EBITDA-6.79M-17.61M39%
Gain YTD-47.619-56.49384%
P/E RatioN/A49.50-
Revenue56.4M592M10%
Total Cash9.82M415M2%
Total Debt1.26M612M0%
FUNDAMENTALS RATINGS
IRIX vs NEO: Fundamental Ratings
IRIX
NEO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9993
PRICE GROWTH RATING
1..100
8889
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (73) in the Medical Or Nursing Services industry is in the same range as IRIX (91) in the Medical Specialties industry. This means that NEO’s stock grew similarly to IRIX’s over the last 12 months.

NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as IRIX (100) in the Medical Specialties industry. This means that NEO’s stock grew similarly to IRIX’s over the last 12 months.

NEO's SMR Rating (93) in the Medical Or Nursing Services industry is in the same range as IRIX (99) in the Medical Specialties industry. This means that NEO’s stock grew similarly to IRIX’s over the last 12 months.

IRIX's Price Growth Rating (88) in the Medical Specialties industry is in the same range as NEO (89) in the Medical Or Nursing Services industry. This means that IRIX’s stock grew similarly to NEO’s over the last 12 months.

IRIX's P/E Growth Rating (1) in the Medical Specialties industry is significantly better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that IRIX’s stock grew significantly faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRIXNEO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
IRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OLMA4.620.06
+1.32%
Olema Pharmaceuticals
NEMTF125.02N/A
N/A
Nemetschek AG
EFSC55.73-0.05
-0.09%
Enterprise Financial Services Corp
AM18.89-0.03
-0.16%
Antero Midstream Corp
MLSS0.73-0.03
-4.34%
Milestone Scientific

IRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRIX has been loosely correlated with NTRA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if IRIX jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRIX
1D Price
Change %
IRIX100%
-0.69%
NTRA - IRIX
34%
Loosely correlated
-0.12%
MDXH - IRIX
27%
Poorly correlated
+5.50%
NEO - IRIX
26%
Poorly correlated
+0.14%
DRIO - IRIX
26%
Poorly correlated
-2.20%
DHR - IRIX
26%
Poorly correlated
-1.16%
More

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with RGEN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
+0.14%
RGEN - NEO
43%
Loosely correlated
-0.52%
FLGT - NEO
39%
Loosely correlated
+0.41%
NNOX - NEO
36%
Loosely correlated
-0.38%
BLFS - NEO
36%
Loosely correlated
+0.56%
VCYT - NEO
36%
Loosely correlated
+2.13%
More